A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
Clinical trial NCT04637009 · TERMINATED
Trial details
- NCT number
- NCT04637009
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2023-02-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.